NCT04832685View on ClinicalTrials.gov

Neuromodulation of Mind-Wandering in Depression

NAActive, not recruitingINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Depression

Interventions

DEVICE

BrainSonix Pulsar 1002

Device that delivers low intensity focused ultrasound

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER